TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Phase II study of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone immunochemotherapy followed by yttrium-90-ibritumomab tiuxetan in untreated mantle-cell lymphoma: Eastern Cooperative Oncology Group Study E1499.

Mitchell R Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.